Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.
For the first study, published yesterday in eClinicalMedicine, an international roster of researchers in the INTERCOVID consortium mined data from 6,527 pregnant women with and without a COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results